The European Society for Medical Oncology (ESMO) announced the professionals selected for its 2026 Fellowship Programme, including Maria Vieito and…
Fundació ‘la Caixa’
Large-Scale Cancer Genomics Data Reveals Biomarkers That Might Spare Patients Ineffective Treatments
A study led by the Computational Immunogenomics Group at the Vall d’Hebron Institute of Oncology (VHIO), in collaboration with the…
Pharmaceutical company Gilead held the award ceremony for the 11th and 12th editions of the Gilead Biomedical Research Grants this…
From April 17 to 22, the American Association for Cancer Research (AACR) Annual Meeting was held in San Diego. Researchers…
Investigators from VHIO, which is part of the Vall Hebron Campus, publish the first study to address the impact of…
After more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del…
Sponsored by F. Hoffmann-La Roche Ltd, in collaboration with Vall d’Hebron Institute of Oncology (VHIO), a first-in-human clinical trial was…
VHIO played a prominent role at the ESMO Targeted Anticancer Therapies (TAT) congress, one of the leading international forums in…
The 2025 edition of the Health Research call from the “la Caixa” Foundation has selected 34 new cutting-edge biomedical research…
Reported at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, results from four multicenter early phase…
